Skip to main content
Home / Current Alzheimer Research, Volume 4, Number 4
Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

More about this publication?
Volume 4, Number 4, 2007

Articles

Editorial [Hot Topic: Advances in Alzheimer Therapy: Development of Innovative New Strategies (Guest Editors: Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri)]
pp. 336-339(4)
Authors: Greig, Nigel H.; Giacobini, Ezio; Lahiri, Debomoy K.

Favourites:
ADD

Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
pp. 340-350(11)
Authors: Mufson, Elliott J.; Counts, Scott E.; Fahnestock, Margaret; Ginsberg, Stephen D.

Favourites:
ADD

NGF-Cholinergic Dependency in Brain Aging, MCI and Alzheimer's Disease
pp. 351-358(8)
Authors: Cuello, A. C.; Bruno, A.; Bell, K.F. S.

Favourites:
ADD

Amyloid Beta Protein as a Marker or Risk Factor of Alzheimer's Disease
pp. 359-363(5)
Author: Mehta, Pankaj D.

Favourites:
ADD

Computerized Methods in the Assessment and Prediction of Dementia
pp. 364-369(6)
Authors: Korczyn, Amos D.; Aharonson, Vered

Favourites:
ADD

Practical Issues in Stem Cell Therapy for Alzheimer's Disease
pp. 370-377(8)
Authors: Sugaya, K.; Kwak, Y. D.; Ohmitsu, O.; Marutle, A.; Greig, N. H.; Choumrina, E.

Favourites:
ADD

TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets
pp. 378-385(8)
Authors: Tweedie, David; Sambamurti, Kumar; Greig, Nigel H.

Favourites:
ADD

East Meets West in the Search for Alzheimer's Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A
pp. 386-396(11)
Authors: Li, W. M.; Kan, K. K.W.; Carlier, P. R.; Pang, Y. P.; Han, Y. F.

Favourites:
ADD

N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy
pp. 397-402(6)
Authors: Pickhardt, M.; Biernat, J.; Khlistunova, I.; Wang, Y.-P.; Gazova, Z.; Mandelkow, E.-M.; Mandelkow, E.

Favourites:
ADD

Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG
pp. 403-411(9)
Authors: Avramovich-Tirosh, Yael; Reznichenko, Lydia; Amit, Tamar; Zheng, Hailin; Fridkin, Mati; Weinreb, Orly; Mandel, Silvia; Youdim, Moussa B.H.

Favourites:
ADD

Alpha-Secretase As a Therapeutic Target
pp. 412-417(6)
Author: Fahrenholz, Falk

Favourites:
ADD

Memapsin 2 (Beta-Secretase) Inhibitor Drug, between Fantasy and Reality
pp. 418-422(5)
Authors: Ghosh, Arun K.; Bilcer, Geoffrey; Hong, Lin; Koelsch, Gerald; Tang, Jordan

Favourites:
ADD

The γ /η-Secretase-Derived APP Intracellular Domain Fragments Regulate p53
pp. 423-426(4)
Authors: Checler, Frederic; Sunyach, Claire; Pardossi-Piquard, Raphaelle; Sevalle, Jean; Vincent, Bruno; Kawarai, Toshitaka; Girardot, Nadege; George-Hyslop, Peter St; da Costa, Cristine A.

Favourites:
ADD

Novel Aβ Immunogens: Is Shorter Better?
pp. 427-436(10)
Authors: Lemere, Cynthia A.; Maier, Marcel; Peng, Ying; Jiang, Liying; Seabrook, Timothy J.

Favourites:
ADD

A Novel Immunotherapy for Alzheimer's Disease: Antibodies against the β-Secretase Cleavage Site of APP
pp. 437-445(9)
Authors: Arbel, Michal; Solomon, Beka

Favourites:
ADD

Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
pp. 446-457(12)
Authors: Windisch, M.; Wolf, H. J.; Hutter-Paier, B.; Hofmeister, A.; Wronski, R.

Favourites:
ADD

Lessons from Darwin: 21st Century Designs for Clinical Trials
pp. 458-467(10)
Author: Becker, Robert E.

Favourites:
ADD

Drug Trials in Dementia: Challenging Ethical Dilemmas
pp. 468-472(5)
Author: Korczyn, Amos D.

Favourites:
ADD

Alzhemed: A Potential Treatment for Alzheimer's Disease
pp. 473-478(6)
Authors: Aisen, Paul S.; Gauthier, Serge; Vellas, Bruno; Briand, Richard; Saumier, Daniel; Laurin, Julie; Garceau, Denis

Favourites:
ADD

Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimer's Disease Pharmacogenetics
pp. 479-500(22)
Authors: Cacabelos, Ramon; Llovo, Ruth; Fraile, Carmen; Fernandez-Novoa, Lucia

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content